NO169539C - Analogifremgangsmaate til fremstilling av terapeutisk aktive kondenserte diazepinoner - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive kondenserte diazepinoner

Info

Publication number
NO169539C
NO169539C NO892152A NO892152A NO169539C NO 169539 C NO169539 C NO 169539C NO 892152 A NO892152 A NO 892152A NO 892152 A NO892152 A NO 892152A NO 169539 C NO169539 C NO 169539C
Authority
NO
Norway
Prior art keywords
image
preparation
properties
condensed diazepinones
compounds
Prior art date
Application number
NO892152A
Other languages
English (en)
Norwegian (no)
Other versions
NO892152D0 (no
NO169539B (no
NO892152L (no
Inventor
Wolfhard Engel
Wolfgang Eberlein
Gerhard Mihm
Guenter Trummlitz
Norbert Mayer
Adriaan De Jonge
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO892152D0 publication Critical patent/NO892152D0/no
Publication of NO892152L publication Critical patent/NO892152L/no
Publication of NO169539B publication Critical patent/NO169539B/no
Publication of NO169539C publication Critical patent/NO169539C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/38—[b, e]- or [b, f]-condensed with six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Thermal Transfer Or Thermal Recording In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO892152A 1988-05-30 1989-05-29 Analogifremgangsmaate til fremstilling av terapeutisk aktive kondenserte diazepinoner NO169539C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3818299A DE3818299A1 (de) 1988-05-30 1988-05-30 Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (4)

Publication Number Publication Date
NO892152D0 NO892152D0 (no) 1989-05-29
NO892152L NO892152L (no) 1989-12-01
NO169539B NO169539B (no) 1992-03-30
NO169539C true NO169539C (no) 1992-07-08

Family

ID=6355412

Family Applications (1)

Application Number Title Priority Date Filing Date
NO892152A NO169539C (no) 1988-05-30 1989-05-29 Analogifremgangsmaate til fremstilling av terapeutisk aktive kondenserte diazepinoner

Country Status (17)

Country Link
US (1) US5006522A (fi)
EP (1) EP0344543B1 (fi)
JP (1) JPH0228163A (fi)
KR (1) KR900018101A (fi)
AT (1) ATE78479T1 (fi)
AU (1) AU617814B2 (fi)
DD (1) DD283822A5 (fi)
DE (2) DE3818299A1 (fi)
DK (1) DK261289A (fi)
FI (1) FI892596A (fi)
HU (1) HU203887B (fi)
IL (1) IL90418A0 (fi)
NO (1) NO169539C (fi)
NZ (1) NZ229307A (fi)
PT (1) PT90677B (fi)
SU (1) SU1731057A3 (fi)
ZA (1) ZA894048B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3726908A1 (de) * 1987-08-13 1989-02-23 Thomae Gmbh Dr K Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
ATE161535T1 (de) * 1989-04-20 1998-01-15 Boehringer Ingelheim Pharma 6,11-dihydro-5h-pyrido(2,3-b)(1,5)benzodiazepin 5-one und thione und ihre verwendung für die vorbeugung oder behandlung von aids
DE3919076A1 (de) * 1989-06-10 1990-12-13 Thomae Gmbh Dr K Mittel zur behandlung von erkrankungen des zentralnervensystems und zur foerderung der cerebralen durchblutung
PT693070E (pt) * 1993-04-05 2002-12-31 Pharmaceutical Discovery Corp Pirido(2,3-b)(1,4)benzodiazepinonas como ligando do receptor m2 para o tratamento de desordens neurologicas
US5561127A (en) * 1994-12-19 1996-10-01 Allelix Biopharmaceuticals, Inc. Muscarinic receptor ligands
JP3521569B2 (ja) * 1995-09-05 2004-04-19 ブラザー工業株式会社 印字制御装置
FR2850654A1 (fr) * 2003-02-03 2004-08-06 Servier Lab Nouveaux derives d'azepines tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2691844A1 (en) * 2007-07-02 2009-01-08 Ac Immune S.A. Therapeutic compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3150125A (en) * 1959-09-22 1964-09-22 Wander Ag Dr A 5-(basic substituted)-10, 11-dihydro-11-oxo-5h-dibenzo[b, e][1, 4]diazepine compounds
US3105125A (en) * 1959-10-30 1963-09-24 Bell Telephone Labor Inc Power separation filter
ATE71097T1 (de) * 1985-06-27 1992-01-15 Thomae Gmbh Dr K In 11-stellung substituierte 5,11-dihydro-6hpyrido-(2,3-b>(1,4>benzodiazepin-6-one, verfahren zur ihrer herstellung und diese verbindungen enthaltende arzneimittel.
US4749788A (en) * 1987-04-13 1988-06-07 A. H. Robins Company, Incorporated Process for the preparation of aryl-pyrido(1,4) benzodiazepines
DE3819444A1 (de) * 1988-06-08 1989-12-14 Thomae Gmbh Dr K Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3820346A1 (de) * 1988-06-15 1989-12-21 Thomae Gmbh Dr K Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
NO892152D0 (no) 1989-05-29
FI892596A0 (fi) 1989-05-29
US5006522A (en) 1991-04-09
NO169539B (no) 1992-03-30
SU1731057A3 (ru) 1992-04-30
FI892596A (fi) 1989-12-01
PT90677A (pt) 1989-11-30
PT90677B (pt) 1994-11-30
ATE78479T1 (de) 1992-08-15
ZA894048B (en) 1991-02-27
EP0344543B1 (de) 1992-07-22
AU617814B2 (en) 1991-12-05
NO892152L (no) 1989-12-01
DE3818299A1 (de) 1989-12-07
EP0344543A3 (en) 1990-08-22
HU203887B (en) 1991-10-28
DK261289A (da) 1989-12-01
HUT50343A (en) 1990-01-29
NZ229307A (en) 1990-11-27
JPH0228163A (ja) 1990-01-30
AU3585089A (en) 1989-11-30
IL90418A0 (en) 1990-01-18
EP0344543A2 (de) 1989-12-06
KR900018101A (ko) 1990-12-20
DK261289D0 (da) 1989-05-29
DD283822A5 (de) 1990-10-24
DE58901872D1 (de) 1992-08-27

Similar Documents

Publication Publication Date Title
DE69012591D1 (de) Verwendung von Nikotin zur Herstellung eines Kit zur Behandlung von Krankheitszuständen, die auf eine Nikotinbehandlung ansprechen.
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
BR9714677A (pt) "enantiÈmeros 3-piridila e seu uso como analgésicos"
NO169539C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive kondenserte diazepinoner
Miller et al. L-tryptophan in the treatment of levodopa induced psychiatric disorders.
DE60108130D1 (de) Pharmazeutische zusammensetzungen zur behandlung von neurologischen krankheiten
SG48793A1 (en) Condensed diazepiones processes for preparing them and agents containing these compounds for treating diseases of the central nervous system and for promoting cerebral blood circulation
DE69315162D1 (de) Verwendung von L-Carnitine und Acyl-L-Carnitinen zur Behandlung von Patienten die an AIDS-verwandten Syndromen leiden und von asymptomatischen HIV-seropositiven Patienten
SG67287A1 (en) New derivatives of physostigmine their use and pharmaceutical formulation containing them
NO161494C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive benzodiazepiner.
DE69307702D1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
DE59709081D1 (de) Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung und Prävention der Alzheimer'schen Krankheit
NO961180L (no) Transdermal anordning inneholdende (E)-2-(p-fluorfenetyl)-3-fluorallylamin for behandling av Alzheimers sykdom
Small et al. " Topographic brain mapping: Applications and pitfalls": Commentary.
NO156410C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6aaa-methylprednisolonderivater.
DE3887005D1 (de) Mittel zur Behandlung von Nierenbeschwerden.